Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer

Zeynep Irem Ozay, Yeonjung Jo, Georges Gebrael, Micah Ostrowski, Vinay Mathew Thomas, Haoran Li, Ryon P. Graf, Soumyajit Roy, Benjamin L. Maughan, Avirup Guha, Irbaz Bin Riaz, Emmanuel S. Antonarakis, Rana R. McKay, Neeraj Agarwal, Umang Swami · 2026

Read Bone-Modifying Agents in Metastatic Castration-Resistant Prostate Cancer by Zeynep Irem Ozay, Yeonjung Jo, Georges Gebrael, Micah Ostrowski, Vinay Mathew Thomas, Haoran Li, Ryon P. Graf, Soumyajit Roy, Benjamin L. Maughan, Avirup Guha, Irbaz Bin Riaz, Emmanuel S. Antonarakis, Rana R. McKay, Neeraj Agarwal, Umang Swami (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13294771.txt.

Description

Zeynep Irem Ozay and co-authors chart how often American men with advanced prostate cancer receive bone-protecting drugs, in a 2026 cohort study. More than ninety percent of men whose prostate cancer resists hormone therapy develop bone spread, and a third suffer fractures or other skeletal events. Two drugs, denosumab and zoledronic acid, can delay those events, yet earlier work suggested they are underused. The team mined records from some 280 United States cancer clinics covering 2013 to 2024.

Among more than fourteen thousand patients, about fifty-seven percent had some record of receiving a bone-modifying agent after diagnosis, leaving forty-three percent without. Recipients were more often treated in community practices and more often held commercial insurance than non-recipients. The study updates the usage picture for a therapy that guidelines support, giving clinics a benchmark for finding missed patients.

Catalog record

CREATORZeynep Irem Ozay, Yeonjung Jo, Georges Gebrael, Micah Ostrowski, Vinay Mathew Thomas, Haoran Li, Ryon P. Graf, Soumyajit Roy, Benjamin L. Maughan, Avirup Guha, Irbaz Bin Riaz, Emmanuel S. Antonarakis, Rana R. McKay, Neeraj Agarwal, Umang Swami
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE8 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13294771

Browse the full library · About the Tower of Babel